Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non–small-cell lung cancer: A randomized trial

Branislav Jeremic, Yuta Shibamoto, Ljubisa Acimovic, Biljana Milicic, Slobodan Milisavljevic, Nebojsa Nikolic, Aleksandar Dagovic, Jasna Aleksandrovic, Gordana Radosavljevic-Asic

Open source

DOI: 10.1016/s0360-3016(00)01546-7
Published: 2001-05
Container: International Journal of Radiation Oncology*Biology*Physics
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0360-3016-00-01546-7,
  title = {Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non–small-cell lung cancer: A randomized trial},
  author = {Branislav Jeremic and Yuta Shibamoto and Ljubisa Acimovic and Biljana Milicic and Slobodan Milisavljevic and Nebojsa Nikolic and Aleksandar Dagovic and Jasna Aleksandrovic and Gordana Radosavljevic-Asic},
  year = {2001},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  doi = {10.1016/s0360-3016(00)01546-7},
  url = {https://doi.org/10.1016/s0360-3016(00)01546-7}
}

RIS

TY  - JOUR
TI  - Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non–small-cell lung cancer: A randomized trial
AU  - Branislav Jeremic
AU  - Yuta Shibamoto
AU  - Ljubisa Acimovic
AU  - Biljana Milicic
AU  - Slobodan Milisavljevic
AU  - Nebojsa Nikolic
AU  - Aleksandar Dagovic
AU  - Jasna Aleksandrovic
AU  - Gordana Radosavljevic-Asic
PY  - 2001
JO  - International Journal of Radiation Oncology*Biology*Physics
DO  - 10.1016/s0360-3016(00)01546-7
UR  - https://doi.org/10.1016/s0360-3016(00)01546-7
ER  -

APA

Jeremic, B., Shibamoto, Y., Acimovic, L., Milicic, B., Milisavljevic, S., Nikolic, N., Dagovic, A., Aleksandrovic, J., & Radosavljevic-Asic, G. (2001). Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non–small-cell lung cancer: A randomized trial. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/s0360-3016(00)01546-7

Source records

crossref · retrieved 2026-11-10T13:45:46.350Z